HB1796: Allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions.
Introduced
House
Summary
Allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions.
Sponsors
Michael Moffett
R - HD-04-MER
Primary
Henry Giasson
R - HD-29-HIL
Co-sponsor
Jennifer Mandelbaum
D - HD-21-ROC
Co-sponsor
Tom Mannion
R - HD-01-HIL
Co-sponsor
Carol McGuire
R - HD-27-MER
Co-sponsor
Terry Roy
R - HD-31-ROC
Co-sponsor
Matt Sabourin
R - HD-30-ROC
Co-sponsor
Howard Pearl
R - SD-017
Co-sponsor
David Watters
D - SD-004
Co-sponsor
History
- 2025-12-17 Introduced 01/07/2026 and referred to Health, Human Services and Elderly Affairs House Journal 1 P. 36
- 2026-01-08 Public Hearing: 01/14/2026 02:00 pm GP 158
- 2026-01-21 Executive Session: 01/28/2026 02:30 pm GP 158
- 2026-02-03 Majority Committee Report: Inexpedient to Legislate 01/28/2026 (Vote 11-7; Regular Calendar) House Calendar 10 P. 91
- 2026-02-03 Minority Committee Report: Ought to Pass
Committee Referrals
2025-12-17
Health, Human Services & Elderly Affairs
House
Calendar Events
Past Events (2)
2026-01-14
Hearing - GP 158
2026-01-28
Hearing - GP 158